Steven Ledger is the founder of Serina Therapeutics. Serina Therapeutics has raised $15M in total funding. Latest round: Series A. Backed by Greg Bailey.
Steven Ledger was appointed Chief Executive Officer of Serina Therapeutics effective September 8, 2024, after serving as Interim CEO during the company's merger with AgeX Therapeutics. He leads Serina Therapeutics, a biotechnology company based in Huntsville, Alabama, focused on developing therapies for age-related diseases. His appointment marked a key leadership transition for the company.
Full founder directory · Investor directory · Company funding database · Fundraising library